Analyst
Barclays
Equibles does not estimate personal net worth.
Matt Nixick is recorded as Analyst at Barclays. Matt Nixick has spoken on 4 earnings calls across 3 companies, most recently for Baxter International Inc on April 30, 2026. Those appearances were for Dexcom Inc (DXCM), Baxter International Inc (BAX) and Stryker Corp (SYK). The companies whose calls Matt Nixick spoke on are classified in the Healthcare sector.
“And congrats on a great start to the year. I wanted to follow up on just a couple things. One on the general macro factors that are causing some concerns, I guess, and in the past had been a challenge for Baxter.”
“I'm out to maybe, we covered a lot here, but maybe follow up on Stello. Last year, I think, ahead of some of the coverage that you talked about earlier in the year, it was maybe, it seemed to have maybe a slightly different role, slightly different target potential, maybe.”
“So just one quick clarification and then a question on some of the comments you made about economics of patients. So the quick clarification was just, I'm not sure if you've given a timeframe for G8 yet approximately.”
Barclays
Analyst
Transcript header (unverified)
DXCM
Medical Devices · Healthcare
Medical Instruments & Supplies · Healthcare
SYK
Medical Devices · Healthcare
